Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1385/ijgc:32:1:1.

Title:
The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer | Journal of Gastrointestinal Cancer
Description:
Background. Resected pancreatic cancer has a high risk of recurrence and mortality despite the the use of chemoradiotherapy. Because pancreatic cancers express tumor antigens such as carcinoembryonic antigen (CEA), it may be possible to immunize patients to induce tumor antigen-specific immune responses. We hypothesize that high-frequency tumor antigen-specific immune responses will reduce recurrence and increase survival. Autologous dendritic cells (DCs) loaded with tumor antigens are particularly potent at inducing tumor antigen-specific immune responses. Methods. Three patients with resected pancreatic adenocarcinoma following neoadjuvant chemoradiotherapy received autologous, monocyte-derived DCs loaded with the mRNA encoding CEA monthly for 6 mo. Results. It was feasible to generate an adequate number of DC from these patients and to cryopreserve them for repeated use. The DC demonstrated the typical immature phenotype. The immunizations were well-tolerated without evidence of adverse events. All three developed injection site reactivity. All three are alive without evidence of disease at more than 21/2 yr from the original diagnosis. Conclusion. The postoperative period following neoadjuvant chemoradiotherapy and pancreaticoduo-denectomy for pancreatic cancer is an ideal environment to test novel immune-based therapies. DC-based immunotherapy in this setting is safe and feasible and may lead to prolonged survival.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Science
  • Health & Fitness
  • Education

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

The income method remains a mystery to us.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {πŸ”}

article, cancer, pancreatic, pubmed, cas, google, scholar, dendritic, cells, patients, immunotherapy, cea, tumor, morse, adenocarcinoma, access, privacy, cookies, content, journal, loaded, neoadjuvant, chemoradiotherapy, nair, lyerly, antigen, responses, usa, publish, search, mrna, resection, kim, carcinoembryonic, immune, survival, autologous, peptide, int, author, data, information, log, research, gastrointestinal, safety, boczkowski, hurwitz, schlom, gilboa,

Topics {βœ’οΈ}

granulocyte-macrophage colony-stimulating factors anti-ceacam6 antibody-based conjugates month download article/chapter autologous dendritic cells dendritic cells loaded recombinant ga733-2e antigen related subjects dendritic cells monocyte-derived dcs loaded article international journal gastro-intestinal carcinoma patients full article pdf dc-based immunotherapy immune-based therapies privacy choices/manage cookies carcinoembryonic antigen peptide resected pancreatic cancer gastrointestinal cancer aims brain metastases european economic area typical immature phenotype melanoma patient vaccinated tumor antigens resected pancreatic adenocarcinoma conditions privacy policy surg clin north received definitive surgery pancreatic tumor journal finder publish check access instant access article morse accepting optional cookies kim lyerly long term survival active immunotherapy article log cea mrna author correspondence pancreatic adenocarcinoma patients carcinoembryonic antigen immunological responses alan proia article cite immune activation pancreatic cancer cea peptide high risk morse ma pancreatic carcinoma

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer
         description: Background. Resected pancreatic cancer has a high risk of recurrence and mortality despite the the use of chemoradiotherapy. Because pancreatic cancers express tumor antigens such as carcinoembryonic antigen (CEA), it may be possible to immunize patients to induce tumor antigen-specific immune responses. We hypothesize that high-frequency tumor antigen-specific immune responses will reduce recurrence and increase survival. Autologous dendritic cells (DCs) loaded with tumor antigens are particularly potent at inducing tumor antigen-specific immune responses. Methods. Three patients with resected pancreatic adenocarcinoma following neoadjuvant chemoradiotherapy received autologous, monocyte-derived DCs loaded with the mRNA encoding CEA monthly for 6 mo. Results. It was feasible to generate an adequate number of DC from these patients and to cryopreserve them for repeated use. The DC demonstrated the typical immature phenotype. The immunizations were well-tolerated without evidence of adverse events. All three developed injection site reactivity. All three are alive without evidence of disease at more than 21/2 yr from the original diagnosis. Conclusion. The postoperative period following neoadjuvant chemoradiotherapy and pancreaticoduo-denectomy for pancreatic cancer is an ideal environment to test novel immune-based therapies. DC-based immunotherapy in this setting is safe and feasible and may lead to prolonged survival.
         datePublished:
         dateModified:
         pageStart:1
         pageEnd:6
         sameAs:https://doi.org/10.1385/IJGC:32:1:1
         keywords:
            Dendritic cells
            CEA
            mRNA
            pancreatic cancer
            immunotherapy
            Oncology
            Gastroenterology
            Radiotherapy
            Cancer Research
            Internal Medicine
         image:
         isPartOf:
            name:International Journal of Gastrointestinal Cancer
            issn:
               1559-0739
               1537-3649
            volumeNumber:32
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Humana Press
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Michael A. Morse
               affiliation:
                     name:Duke University Medical Center
                     address:
                        name:Department of Medicine, Duke University Medical Center, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Smita K. Nair
               affiliation:
                     name:Duke University Medical Center
                     address:
                        name:Department of Surgery, Duke University Medical Center, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:David Boczkowski
               affiliation:
                     name:Duke University Medical Center
                     address:
                        name:Department of Surgery, Duke University Medical Center, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Douglas Tyler
               affiliation:
                     name:Duke University Medical Center
                     address:
                        name:Department of Surgery, Duke University Medical Center, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Herbert I. Hurwitz
               affiliation:
                     name:Duke University Medical Center
                     address:
                        name:Department of Medicine, Duke University Medical Center, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Alan Proia
               affiliation:
                     name:Duke University Medical Center
                     address:
                        name:Department of Pathology, Duke University Medical Center, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Timothy M. Clay
               affiliation:
                     name:Duke University Medical Center
                     address:
                        name:Department of Surgery, Duke University Medical Center, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jeffrey Schlom
               affiliation:
                     name:National Institutes of Health
                     address:
                        name:National Institutes of Health, Bethesda
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Eli Gilboa
               affiliation:
                     name:Duke University Medical Center
                     address:
                        name:Department of Surgery, Duke University Medical Center, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:H. Kim Lyerly
               affiliation:
                     name:Duke University Medical Center
                     address:
                        name:Department of Surgery, Duke University Medical Center, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer
      description: Background. Resected pancreatic cancer has a high risk of recurrence and mortality despite the the use of chemoradiotherapy. Because pancreatic cancers express tumor antigens such as carcinoembryonic antigen (CEA), it may be possible to immunize patients to induce tumor antigen-specific immune responses. We hypothesize that high-frequency tumor antigen-specific immune responses will reduce recurrence and increase survival. Autologous dendritic cells (DCs) loaded with tumor antigens are particularly potent at inducing tumor antigen-specific immune responses. Methods. Three patients with resected pancreatic adenocarcinoma following neoadjuvant chemoradiotherapy received autologous, monocyte-derived DCs loaded with the mRNA encoding CEA monthly for 6 mo. Results. It was feasible to generate an adequate number of DC from these patients and to cryopreserve them for repeated use. The DC demonstrated the typical immature phenotype. The immunizations were well-tolerated without evidence of adverse events. All three developed injection site reactivity. All three are alive without evidence of disease at more than 21/2 yr from the original diagnosis. Conclusion. The postoperative period following neoadjuvant chemoradiotherapy and pancreaticoduo-denectomy for pancreatic cancer is an ideal environment to test novel immune-based therapies. DC-based immunotherapy in this setting is safe and feasible and may lead to prolonged survival.
      datePublished:
      dateModified:
      pageStart:1
      pageEnd:6
      sameAs:https://doi.org/10.1385/IJGC:32:1:1
      keywords:
         Dendritic cells
         CEA
         mRNA
         pancreatic cancer
         immunotherapy
         Oncology
         Gastroenterology
         Radiotherapy
         Cancer Research
         Internal Medicine
      image:
      isPartOf:
         name:International Journal of Gastrointestinal Cancer
         issn:
            1559-0739
            1537-3649
         volumeNumber:32
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Humana Press
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Michael A. Morse
            affiliation:
                  name:Duke University Medical Center
                  address:
                     name:Department of Medicine, Duke University Medical Center, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Smita K. Nair
            affiliation:
                  name:Duke University Medical Center
                  address:
                     name:Department of Surgery, Duke University Medical Center, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:David Boczkowski
            affiliation:
                  name:Duke University Medical Center
                  address:
                     name:Department of Surgery, Duke University Medical Center, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Douglas Tyler
            affiliation:
                  name:Duke University Medical Center
                  address:
                     name:Department of Surgery, Duke University Medical Center, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Herbert I. Hurwitz
            affiliation:
                  name:Duke University Medical Center
                  address:
                     name:Department of Medicine, Duke University Medical Center, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alan Proia
            affiliation:
                  name:Duke University Medical Center
                  address:
                     name:Department of Pathology, Duke University Medical Center, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Timothy M. Clay
            affiliation:
                  name:Duke University Medical Center
                  address:
                     name:Department of Surgery, Duke University Medical Center, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jeffrey Schlom
            affiliation:
                  name:National Institutes of Health
                  address:
                     name:National Institutes of Health, Bethesda
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Eli Gilboa
            affiliation:
                  name:Duke University Medical Center
                  address:
                     name:Department of Surgery, Duke University Medical Center, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:H. Kim Lyerly
            affiliation:
                  name:Duke University Medical Center
                  address:
                     name:Department of Surgery, Duke University Medical Center, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:International Journal of Gastrointestinal Cancer
      issn:
         1559-0739
         1537-3649
      volumeNumber:32
Organization:
      name:Humana Press
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Duke University Medical Center
      address:
         name:Department of Medicine, Duke University Medical Center, USA
         type:PostalAddress
      name:Duke University Medical Center
      address:
         name:Department of Surgery, Duke University Medical Center, USA
         type:PostalAddress
      name:Duke University Medical Center
      address:
         name:Department of Surgery, Duke University Medical Center, USA
         type:PostalAddress
      name:Duke University Medical Center
      address:
         name:Department of Surgery, Duke University Medical Center, USA
         type:PostalAddress
      name:Duke University Medical Center
      address:
         name:Department of Medicine, Duke University Medical Center, USA
         type:PostalAddress
      name:Duke University Medical Center
      address:
         name:Department of Pathology, Duke University Medical Center, USA
         type:PostalAddress
      name:Duke University Medical Center
      address:
         name:Department of Surgery, Duke University Medical Center, USA
         type:PostalAddress
      name:National Institutes of Health
      address:
         name:National Institutes of Health, Bethesda
         type:PostalAddress
      name:Duke University Medical Center
      address:
         name:Department of Surgery, Duke University Medical Center, USA
         type:PostalAddress
      name:Duke University Medical Center
      address:
         name:Department of Surgery, Duke University Medical Center, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Michael A. Morse
      affiliation:
            name:Duke University Medical Center
            address:
               name:Department of Medicine, Duke University Medical Center, USA
               type:PostalAddress
            type:Organization
      name:Smita K. Nair
      affiliation:
            name:Duke University Medical Center
            address:
               name:Department of Surgery, Duke University Medical Center, USA
               type:PostalAddress
            type:Organization
      name:David Boczkowski
      affiliation:
            name:Duke University Medical Center
            address:
               name:Department of Surgery, Duke University Medical Center, USA
               type:PostalAddress
            type:Organization
      name:Douglas Tyler
      affiliation:
            name:Duke University Medical Center
            address:
               name:Department of Surgery, Duke University Medical Center, USA
               type:PostalAddress
            type:Organization
      name:Herbert I. Hurwitz
      affiliation:
            name:Duke University Medical Center
            address:
               name:Department of Medicine, Duke University Medical Center, USA
               type:PostalAddress
            type:Organization
      name:Alan Proia
      affiliation:
            name:Duke University Medical Center
            address:
               name:Department of Pathology, Duke University Medical Center, USA
               type:PostalAddress
            type:Organization
      name:Timothy M. Clay
      affiliation:
            name:Duke University Medical Center
            address:
               name:Department of Surgery, Duke University Medical Center, USA
               type:PostalAddress
            type:Organization
      name:Jeffrey Schlom
      affiliation:
            name:National Institutes of Health
            address:
               name:National Institutes of Health, Bethesda
               type:PostalAddress
            type:Organization
      name:Eli Gilboa
      affiliation:
            name:Duke University Medical Center
            address:
               name:Department of Surgery, Duke University Medical Center, USA
               type:PostalAddress
            type:Organization
      name:H. Kim Lyerly
      affiliation:
            name:Duke University Medical Center
            address:
               name:Department of Surgery, Duke University Medical Center, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Medicine, Duke University Medical Center, USA
      name:Department of Surgery, Duke University Medical Center, USA
      name:Department of Surgery, Duke University Medical Center, USA
      name:Department of Surgery, Duke University Medical Center, USA
      name:Department of Medicine, Duke University Medical Center, USA
      name:Department of Pathology, Duke University Medical Center, USA
      name:Department of Surgery, Duke University Medical Center, USA
      name:National Institutes of Health, Bethesda
      name:Department of Surgery, Duke University Medical Center, USA
      name:Department of Surgery, Duke University Medical Center, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(78)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

3.41s.